The global home infusion therapy market size is poised to reach USD 61.7 billion by 2030. The market is anticipated to expand at a CAGR of 7.9% from 2022 to 2030. The administration of medications at home through catheters and needles is referred to as home infusion therapy. Getting results at home without paying long bills to hospitals has gained people’s attention. The population is more inclined towards affordable and convenient treatment solutions. This, in turn, is further boosting the market growth.
The recent COVID-19 outbreak had a significant impact on the health of a large number of people across the globe. Approximately 700 million people got infected during the pandemic and the number is still increasing in some areas. Thus, people across the globe are putting efforts to focus on one’s health. Amid the situation, in-home treatment has become the preferred treatment option for long-term outcomes. Through the therapy, patients are also provided with immune-boosting nutrition Moreover, the key players operating in the market are focusing on research activities to develop product offerings coupled with the technology to provide effective treatment to patients. Hence, despite the strict lockdown implementations, and halt of supply chain & operations, some major players managed to gain profits during the pandemic.
For instance, In October 2020, according to the MedTech Dive, Baxter International declared their third quarter sales of medical products at around USD 2.97 billion. This value is around a 4% increase in their sales revenue due to the rising demand for COVID-related medications. They have also announced a sales growth of a 6% increase as compared to 2020 sales.
The rise in the geriatric population and the increasing prevalence of chronic diseases are making a pathway for at-home therapy for long-term effects. Moreover, the surge of advanced technology which detects errors and provides treatment with reduced risk is benefitting the home care setting treatments market growth. Monitoring patients remotely is safe and minimize the burden on the healthcare system. In some conditions where oral medications cannot be preferred such as immune deficiencies, cancer, and congestive heart failure, home infusion therapy is suggested. As these patients require long-term medications, the cost reduction is an add-on benefit to treatment at home rather than costly hospital stays, Aforementioned factors are expected to register the demand for home infusion therapy during the forecast period.
Home Infusion Therapy Market Key Takeaways
- Based on the product. the market is segmented into infusion pumps, ambulatory infusion pumps, intravenous sets, IV cannulas, and needleless connectors The infusion pumps dominated the market, accounting for 50% of the total market share in 2021. The increasing demand for syringes and ambulatory pumps is growing the adoption of home healthcare, contributing to the segment growth.
- The smart pumps segment is estimated to expand at a significant growth rate during the forecast period. The in-built technological features of the smart pumps are contributing to the product demand. Barcode technology helps in verifying the patient's identity and avoiding drug administration errors.
- Needless connectors provide enhanced safety, adhere to help good clinical practice (GCP), and enable smooth surgeries. Thus, the segment is anticipated to witness growth during the forecast period.
- Based on application, the market has been segmented into anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, and specialty pharmaceuticals. The anti-infective segment led the market in 2021 accounting for over 25% of the total market share. After the anti-infective segment, the chemotherapy segment is estimated to be fast growing segment during the forecast period. As the number of cases of cancer patients is increasing, the pressure pumps demand is growing, contributing to segment growth.
- North America accounted for the largest market revenue share of 55% in 2021. The availability of new technologies in infusion pumps is driving market growth in the region. Followed by North America, the market in the Asia pacific is estimated to register growth at a CAGR of 9.8% during the forecast period. Growing awareness regarding the advantages of home infusion pumps is creating opportunities for the market to expand in the region.
Home Infusion Therapy Market Segments
- Home Infusion Therapy Product Outlook (Revenue, USD Million, 2017 - 2030)
- Infusion Pumps
- Elastomeric
- Electromechanical
- Gravity
- Others
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
- Home Infusion Therapy Application Outlook (Revenue, USD Million, 2017 - 2030)
- Anti-infective
- Endocrinology
- Hydration Therapy
- Chemotherapy
- Enteral Nutrition
- Parenteral Nutrition
- Specialty Pharmaceuticals
- Others
- Home Infusion Therapy Route of Administration Outlook (Revenue, USD Million, 2017 - 2030)
- Intramuscular
- Subcutaneously
- Epidural
- Home Infusion Therapy Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Netherlands
- Belgium
- Switzerland
- Russia
- Sweden
- Asia Pacific
- India
- Japan
- China
- Australia
- South Korea
- Malaysia
- Indonesia
- Singapore
- Philippines
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Israel
- Egypt
- List of key players of the global home infusion therapy market
- CVS/Coram
- Option Care Health
- CareFusion Corporation
- BriovaRx/Diplomat (UnitedHealth Optum)
- PharMerica
- Fresenius Kabi
- ICU Medical, Inc.
- B. Braun Melsungen AG
- Baxter
- BD
- Caesarea Medical Electronics
- Smiths Medical
- Terumo Corporation
- JMS Co. Ltd.
